Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus

被引:14
|
作者
Kaneko, T. [1 ]
Tada, Y. [1 ]
Maruya, S. [1 ]
Takeishi, E. [1 ]
Miura, K. [1 ]
Masubuchi, T. [1 ]
Fushimi, C. [1 ]
Hasegawa, H. [2 ]
Kamata, S. [1 ]
机构
[1] Int Univ Hlth & Welf, Head & Neck Oncol Ctr, Mita Hosp, Tokyo 1088329, Japan
[2] Fukushima Med Univ, Sch Med, Dept Dent & Oral Surg, Fukushima, Japan
关键词
superficial temporal artery; occipital artery; sodium thiosulphate; definitive irradiation; orbital invasion; SUPERFICIAL TEMPORAL ARTERY; NECK-CANCER; PARANASAL SINUSES; REGIONAL CHEMOTHERAPY; ADVANCED HEAD; NASAL CAVITY; RADIOTHERAPY; INFUSION; SURGERY; TUMORS;
D O I
10.1016/j.ijom.2015.03.009
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
A new intra-arterial chemoraliation regimen that involves infusing low-dose cisplatin in combination with definitive irradiation was used in 36 patients diagnosed with squamous cell carcinoma of the maxillary sinus. The safety and therapeutic efficacy of this regimen were reviewed retrospectively. An intra-arterial catheter was inserted in a retrograde manner into the target artery via the superficial temporal artery or occipital artery. Intra-arterial infusion was performed using cisplatin at a dose of 20-50 mg/m(2) per week for 6-8 weeks. At the same time, sodium thiosulphate was infused as a neutralizing agent. Irradiation was performed at 60 Gy in 30 fractions. All 36 patients completed treatment. Grade 3 adverse events occurred in only seven patients (19.4%) and no grade 4 events were noted. As a primary therapy, the complete response rate was 83.3%, the partial response rate was 16.7%, and the overall response rate was 100%. The 2-year local control rate was 63.0%, and the 2-year overall survival rate was 75.5%. The 2-year preservation rate of the hard palate was 97.1%, that of the eyeball was 97.2%, and that of visual function was 94.4%. This treatment regimen can contribute to improving the quality of life of patients without reducing the curability of the therapy.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 50 条
  • [21] Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma
    Shinohara, Shogo
    Takebayashi, Shinji
    Hamaguchi, Kiyomi
    Michida, Tetsuhiko
    Tobe, Yota
    Ikenaga, Tadashi
    Yasumoto, Mami
    Hamamoto, Ayami
    Imagumbai, Toshiyuki
    Mitsuyoshi, Takamasa
    Ashida, Ryo
    Iwai, Takahiro
    Okabayashi, Shun
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [22] A Phase II Study Of Concomitant Hyperfractionated Radiation Therapy And Double Dose Intra-Arterial Cisplatin For Squamous Cell Carcinoma Of The Head And Neck
    Regine, William F.
    Valentino, Joseph
    Arnold, Susanne M.
    Sloan, David
    Kenady, Daniel
    Strottmann, James
    Mohiuddin, Mohammed
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (02) : 133 - 140
  • [23] Successful treatment of oral squamous cell carcinoma with intra-arterial cisplatin and concurrent radiotherapy
    Koba, Shinichi
    Misago, Noriyuki
    Shirai, Reiko
    Tokumaru, Sunao
    Noguchi, Tomoyuki
    Narisawa, Yutaka
    JOURNAL OF DERMATOLOGY, 2014, 41 (02): : 172 - 173
  • [24] Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents
    Furusaka, Tohru
    Matsuda, Akira
    Tanaka, Akane
    Matsuda, Hiroshi
    Ikeda, Minoru
    ACTA OTO-LARYNGOLOGICA, 2013, 133 (03) : 318 - 326
  • [25] Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors
    Ono, Takeharu
    Tanaka, Norimitsu
    Umeno, Hirohito
    Chitose, Shun-ichi
    Shin, Buichiro
    Aso, Takeichiro
    On, Koutaro
    Hattori, Chikayuki
    Etoh, Hidehiro
    Kakuma, Tatsuyuki
    Abe, Toshi
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2017, 45 (12) : 2128 - 2134
  • [26] A Totally Implanted Intra-Arterial Chemotherapy System for Advanced Maxillary Sinus Carcinoma
    Nakatani, Hiroaki
    Hirose, Kahori
    Matsumoto, Noboru
    Yamakawa, Kazuhiro
    Kakigi, Akinobu
    Takeda, Taizo
    Ito, Satoshi
    Yamanishi, Tomoaki
    Nishioka, Akihito
    Ogawa, Yasuhiro
    Nakahira, Mitsuhiko
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2009, 71 : 116 - 122
  • [27] A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma
    Fujishiro, Yoshinori
    Nakao, Kazunari
    Watanabe, Kenta
    Ebihara, Yasuhiro
    Nakamura, Naoki
    Mori, Harushi
    Hayash, Naoto
    Asakage, Takahiro
    ACTA OTO-LARYNGOLOGICA, 2007, 127 : 151 - 156
  • [28] Treatment Outcome of Combined Radiation Therapy and Intra-arterial (IA) Chemotherapy for Advanced Maxillary Sinus Carcinoma
    Saito, M.
    Tougasaki, G.
    Kanazawa, A.
    Harada, R.
    Nemoto, M. Watanabe
    Isobe, K.
    Uno, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S458 - S458
  • [29] Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma
    Heianna, J.
    Makino, W.
    Hirakawa, H.
    Yamashita, Y.
    Tomita, H.
    Murayama, S.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2022, 51 (09) : 1123 - 1130
  • [30] Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy
    Konishi, Kenta
    Kamiya, Mika
    Ohira, Keiichi
    Hirata, Masanori
    Wakabayashi, Kohei
    Ikenohira, Tsutomu
    Kosugi, Takashi
    Ushio, Takasuke
    Imai, Atsushi
    Mochizuki, Daiki
    Yamaguchi, Yuki
    Tanahashi, Yukichi
    Misawa, Kiyoshi
    Goshima, Satoshi
    Nakamura, Katsumasa
    ANTICANCER RESEARCH, 2023, 43 (06) : 2859 - 2864